Fighting the FDA’s Final Rule on LDTs
CEO Laurie Menser discusses the Association for Molecular Pathology’s court case against the FDA’s rule on laboratory-developed tests.
CEO Laurie Menser discusses the Association for Molecular Pathology’s court case against the FDA’s rule on laboratory-developed tests.
From - Diagnostic Testing & Emerging Technologies
In mid-July, the Senate Finance Committee heard testimony from stakeholders arguing for changes to the Stark Law that could make compliance easier and…